Skip to main content

LAZARD ASSET MANAGEMENT LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1207017 NEW YORK, NY

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$16,398,863
+$7,190,551 QoQ
Shares Held
124,479
+91.7% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 94.33077065207786.ToString("F0")% Shared 0.ToString("F0")% None 5.66922934792214.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

LAZARD ASSET MANAGEMENT LLC holds $165,612,539 across 22 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (9.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
124,479 $16,398,863

All Filings in NBIX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $16,398,863 124,479
2025-12-31 $9,208,312 64,925
2025-09-30 $5,738,313 40,877
2025-06-30 $4,571,847 36,374
2025-03-31 $6,280,089 56,782
2024-12-31 $8,091,583 59,279
2024-09-30 $8,632,511 74,922
2024-06-30 $8,457,480 61,433
2024-03-31 $7,630,975 55,329
2023-12-31 $6,119,593 46,445
2023-09-30 $3,065,962 27,253
2023-06-30 $175,398 1,860
2023-03-31 $4,553,583 44,987
2022-12-31 $505,828 4,235
2022-09-30 $127,770 1,203
2022-06-30 $74,572 765
2022-03-31 $74,156 791
2021-12-31 $4,131,426 48,508
2021-09-30 $3,271,873 34,114
2021-03-31 $88,983 915
2020-12-31 $94,699 988
2020-09-30 $92,313 960
2020-06-30 $142,984 1,172
2020-03-31 $156,915 1,813